More accountable care organizations are taking on downside financial risk in the Medicare Shared Savings Program than ever before, with 37% in the program today participating in these arrangements.

As healthcare continues its hunt to reduce excessive imaging, Yale New Haven Hospital has found its clinical decision support intervention to be remarkably effective.

Advanced Radiology Services has built a data warehouse internally that’s transforming the way its clinicians tackle problems. 

Biotech company BioMarin Pharmaceutical is considering a price point of between $2 million and $3 million for its novel experimental gene therapy for hemophilia patients, the Wall Street Journal reported Jan. 16.

The concept of healthcare providers working with AI technologies still worries some patients.  

Well-to-do individuals shell out thousands—and sometimes tens of thousands—of dollars for “executive” screening programs at top-ranked hospitals. But is that money really well-spent?

A review published in the Journal of the American College of Cardiology this month suggests that an excess of 2 million patients with cardiovascular disease also use marijuana.

A lawsuit alleged radiologist Steven Fuhr spent seconds reading nearly 700 CT scans, missing a brain bleed that led to a patient's eventual death.

The Supreme Court won’t take up the ongoing appeal over the constitutionality of the Affordable Care Act, leaving the decision in the hands of a lower court.

The world could soon have a new most expensive drug if an experimental gene therapy for hemophilia patients could come in with a price tag between $2 million and $3 million is approved.